Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus.
G W Cline, … , D Laurent, G I Shulman
G W Cline, … , D Laurent, G I Shulman
Published May 1, 1997
Citation Information: J Clin Invest. 1997;99(9):2219-2224. https://doi.org/10.1172/JCI119395.
View: Text | PDF
Research Article

Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus.

  • Text
  • PDF
Abstract

To determine the mechanism of impaired insulin-stimulated muscle glycogen metabolism in patients with poorly controlled insulin-dependent diabetes mellitus (IDDM), we used 13C-NMR spectroscopy to monitor the peak intensity of the C1 resonance of the glucosyl units in muscle glycogen during a 6-h hyperglycemic-hyperinsulinemic clamp using [1-(13)C]glucose-enriched infusate followed by nonenriched glucose. Under similar steady state (t = 3-6 h) plasma glucose (approximately 9.0 mM) and insulin concentrations (approximately 400 pM), nonoxidative glucose metabolism was significantly less in the IDDM subjects compared with age-weight-matched control subjects (37+/-6 vs. 73+/-11 micromol/kg of body wt per minute, P < 0.05), which could be attributed to an approximately 45% reduction in the net rate of muscle glycogen synthesis in the IDDM subjects compared with the control subjects (108+/-16 vs. 195+/-6 micromol/liter of muscle per minute, P < 0.001). Muscle glycogen turnover in the IDDM subjects was significantly less than that of the controls (16+/-4 vs. 33+/-5%, P < 0.05), indicating that a marked reduction in flux through glycogen synthase was responsible for the reduced rate of net glycogen synthesis in the IDDM subjects. 31P-NMR spectroscopy was used to determine the intramuscular concentration of glucose-6-phosphate (G-6-P) under the same hyperglycemic-hyperinsulinemic conditions. Basal G-6-P concentration was similar between the two groups (approximately 0.10 mmol/kg of muscle) but the increment in G-6-P concentration in response to the glucose-insulin infusion was approximately 50% less in the IDDM subjects compared with the control subjects (0.07+/-0.02 vs. 0.13+/-0.02 mmol/kg of muscle, P < 0.05). When nonoxidative glucose metabolic rates in the control subjects were matched to the IDDM subjects, the increment in the G-6-P concentration (0.06+/-0.02 mmol/kg of muscle) was no different than that in the IDDM subjects. Together, these data indicate that defective glucose transport/phosphorylation is the major factor responsible for the lower rate of muscle glycogen synthesis in the poorly controlled insulin-dependent diabetic subjects.

Authors

G W Cline, I Magnusson, D L Rothman, K F Petersen, D Laurent, G I Shulman

×

Total citations by year

Year: 2025 2024 2023 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2004 2003 2002 2001 1999 1998 1957 Total
Citations: 1 1 1 1 1 2 2 1 1 1 4 4 1 1 2 1 2 1 1 1 5 3 1 1 40
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (40)

Title and authors Publication Year
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance
Apostolopoulou M, Lambadiari V, Roden M, Dimitriadis GD
Endocrine Reviews 2025
Mechanisms of insulin resistance in type 1 diabetes mellitus: A case of glucolipotoxicity in skeletal muscle
Sammut MJ, Dotzert MS, Melling CW
Journal of Cellular Physiology 2024
Quantifying beta cell function in the preclinical stages of type 1 diabetes.
Galderisi A, Carr ALJ, Martino M, Taylor P, Senior P, Dayan C
Diabetologia 2023
Avocatin B Protects Against Lipotoxicity and Improves Insulin Sensitivity in Diet‐Induced Obesity
N Ahmed, M Tcheng, A Roma, M Buraczynski, P Jayanth, K Rea, TA Akhtar, PA Spagnuolo
Molecular Nutrition & Food Research 2019
Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes
J Shen, B Zhu
Molecular medicine reports 2018
Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes
MV Svart, N Rittig, U Kampmann, TS Voss, N Møller, N Jessen
Diabetologia 2017
Novel hepato-preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes: PORKSEN et al
N Porksen, H Linnebjerg, P Garhyan, EC Lam, MP Knadler, SJ Jacober, U Hoevelmann, L Plum-Moerschel, E Watkins, A Gastaldelli, T Heise
Diabetes, obesity & metabolism 2017
Methodological and physiological test-retest reliability of 13 C-MRS glycogen measurements in liver and in skeletal muscle of patients with type 1 diabetes and matched healthy controls: Test-Retest Reliability of Liver and Muscle Glycogen Determination
T Buehler, L Bally, AS Dokumaci, C Stettler, C Boesch
NMR in Biomedicine 2016
The Interplay of Autoimmunity and Insulin Resistance in Type 1 Diabetes
Natalie J. Nokoff, Marian Rewers, Melanie Cree Green
Discovery medicine 2016
BRIEF REPORT: Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls
L Bally, T Buehler, AS Dokumaci, C Boesch, C Stettler
Diabetes Research and Clinical Practice 2015
Tissue-specific differences in the development of insulin resistance in a mouse model for type 1 diabetes
T Jelenik, G Séquaris, K Kaul, DM Ouwens, E Phielix, J Kotzka, B Knebel, J Weiß, AL Reinbeck, L Janke, P Nowotny, HJ Partke, D Zhang, GI Shulman, J Szendroedi, M Roden
Diabetes 2014
A Fermented Soy Permeate Improves the Skeletal Muscle Glucose Level Without Restoring the Glycogen Content in Streptozotocin-Induced Diabetic Rats
L Malardé, S Vincent, L Lefeuvre-Orfila, T Efstathiou, C Groussard, A Gratas-Delamarche
Journal of Medicinal Food 2013
The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes
BC Bergman, D Howard, IE Schauer, DM Maahs, JK Snell-Bergeon, TW Clement, RH Eckel, L Perreault, M Rewers
The Journal of clinical endocrinology and metabolism 2012
Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes
BC Bergman, D Howard, IE Schauer, DM Maahs, JK Snell-Bergeon, RH Eckel, L Perreault, M Rewers
The Journal of clinical endocrinology and metabolism 2012
Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery
CH Anderwald, A Tura, M Promintzer-Schifferl, G Prager, M Stadler, B Ludvik, H Esterbauer, MG Bischof, A Luger, G Pacini, M Krebs
Diabetes care 2012
The interplay of autoimmunity and insulin resistance in type 1 diabetes
Natalie J Nokoff, Marian Rewers, Melanie Cree Green
Discovery medicine 2012
Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes
M Kacerovsky, A Brehm, M Chmelik, AI Schmid, J Szendroedi, G Kacerovsky-Bielesz, P Nowotny, A Lettner, M Wolzt, JG Jones, M Roden
Journal of Internal Medicine 2011
Metabolic Remodeling of Human Skeletal Myocytes by Cocultured Adipocytes Depends on the Lipolytic State of the System
JP Kovalik, D Slentz, RD Stevens, WE Kraus, JA Houmard, JB Nicoll, YR Lea-Currie, K Everingham, CL Kien, BM Buehrer, DM Muoio
Diabetes 2011
Effects of Gastric Bypass Surgery on Insulin Resistance and Insulin Secretion in Nondiabetic Obese Patients
M Promintzer-Schifferl, G Prager, C Anderwald, M Mandl, H Esterbauer, S Shakeri-Leidenmühler, G Pacini, M Stadler, MG Bischof, B Ludvik, A Luger, M Krebs
Obesity 2011
Dietary antioxidant interventions in type 2 diabetes patients: a meta-analysis
S Akbar, S Bellary, HR Griffiths
The British Journal of Diabetes & Vascular Disease 2011
Textbook of Diabetes
PM Jones, SJ Persaud
Textbook of Diabetes 2010
mTOR function in skeletal muscle: a focal point for overnutrition and exercise
DA Rivas, SJ Lessard, VG Coffey
Applied Physiology, Nutrition, and Metabolism 2009
Metabolomics-based methods for early disease diagnostics
GA Gowda, S Zhang, H Gu, V Asiago, N Shanaiah, D Raftery
Expert Review of Molecular Diagnostics 2008
Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance
TR Koves, JR Ussher, RC Noland, D Slentz, M Mosedale, O Ilkayeva, J Bain, R Stevens, JR Dyck, CB Newgard, GD Lopaschuk, DM Muoio
Cell Metabolism 2008
Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation
AJ Hoy, CR Bruce, A Cederberg, N Turner, DE James, GJ Cooney, EW Kraegen
American journal of physiology. Endocrinology and metabolism 2007
Role of proton MR for the study of muscle lipid metabolism
C Boesch, J Machann, P Vermathen, F Schick
NMR in Biomedicine 2006
In Vivo MR Techniques in Drug Discovery and Development
B Jucker, D Laurent
In Vivo MR Techniques in Drug Discovery and Development 2006
Cerebral pyruvate carboxylase flux is unaltered during bicuculline-seizures
AB Patel, GM Chowdhury, RA de Graaf, DL Rothman, RG Shulman, KL Behar
Journal of Neuroscience Research 2004
In Situ Evidence That Peripheral Insulin Resistance in Adolescents with Poorly Controlled Type 1 Diabetes Is Associated with Impaired Suppression of Lipolysis: A Microdialysis Study
RA Heptulla, A Stewart, S Enocksson, F Rife, TY Ma, RS Sherwin, WV Tamborlane, S Caprio
Pediatric Research 2003
Effects of Obesity on Substrate Utilization during Exercise
BH Goodpaster, RR Wolfe, DE Kelley
Obesity 2002
In vivo13C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during [2-13C]glucose infusion
NR Sibson, GF Mason, J Shen, GW Cline, AZ Herskovits, JE Wall, KL Behar, DL Rothman, RG Shulman
Journal of Neurochemistry 2001
NMR Spectroscopy in β Cell Engineering and Islet Transplantation
KK Papas, CK Colton, JS Gounarides, ES Roos, MA Jarema, MJ Shapiro, LL Cheng, GW Cline, GI Shulman, H Wu, S Bonner-Weir, GC Weir
Annals of the New York Academy of Sciences 2001
Glutamine is the major precursor for GABA synthesis in rat neocortex in vivo following acute GABA-transaminase inhibition
AB Patel, DL Rothman, GW Cline, KL Behar
Brain Research 2001
Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps
LM Perriott, T Kono, RR Whitesell, SM Knobel, DW Piston, DK Granner, AC Powers, JM May
American journal of physiology. Endocrinology and metabolism 2001
Targeted Molecular Imaging in Oncology
EE Kim, DJ Yang
2001
Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity
A Dresner, D Laurent, M Marcucci, ME Griffin, S Dufour, GW Cline, LA Slezak, DK Andersen, RS Hundal, DL Rothman, KF Petersen, GI Shulman
Journal of Clinical Investigation 1999
APPLICATIONS OF NMR SPECTROSCOPY TO STUDY MUSCLE GLYCOGEN METABOLISM IN MAN
MR MD, GI PhD
Annual Review of Medicine 1999
In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives
M Rudin, N Beckmann, R Porszasz, T Reese, D Bochelen, A Sauter
NMR in Biomedicine 1999
A novel 13 C NMR method to assess intracellular glucose concentration in muscle, in vivo
GW Cline, BM Jucker, Z Trajanoski, AJ Rennings, GI Shulman
American journal of physiology. Endocrinology and metabolism 1998
Insulin Resistance
A Voll, J Kloster
Acta Medica Scandinavica 1957

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts